Davis Polk advised Merrill Lynch, Pierce, Fenner & Smith Incorporated, Credit Suisse Securities (USA) LLC and Jefferies LLC as representatives of the several underwriters in connection with the SEC-registered follow-on offering of 8,222,500 shares of common stock of Durata Therapeutics, Inc., including 1,072,500 shares from the full exercise of the underwriters’ option to purchase additional shares, for a price to the public of approximately $57.6 million.

More >>

Cravath represented the underwriters, led by Barclays and Citigroup, in connection with the US$350 million registered convertible senior debt offering of RTI International Metals, Inc., a leading producer and global supplier of titanium mill products and a manufacturer of fabricated titanium and specialty metal components. The transaction closed on April 17, 2013.

More >>

The Firm represented the underwriters, led by Morgan Stanley & Co. LLC, Merrill Lynch, Pierce, Fenner and Smith Incorporated and J.P. Morgan Securities LLC, as joint book-running managers, in connection with a public offering of 6,000,000 shares of 6.50% Non-Cumulative Perpetual Preferred Stock, Series A, $0.01 par value per share, with a liquidation preference of $25 per share, of Texas Capital Bancshares, Inc. (“TCBI”). The offering closed on March 28, 2013.

More >>